Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Computerized Thermal Imaging CIO (formerly COII) -- Ignore unavailable to you. Want to Upgrade?

To: Dr. Bob who wrote (1853)	1/16/1999 12:21:00 PM
From: chirodoc	Read Replies (2) \| Respond to of 6039

you could be right about the timeframe but don't forget that dave said that they should be able to wind everything up in six months also, he said that they would begin submitting information very soon--won't wait six month they will submit in a "modular" fashion this means that we may have approval over many of the elements beginning this spring!! i am assuming that everything should be in this summer then, to get final approval on everything could be another couple months don't forget, there is no issue of danger as with medication no side effects need to be studied and they do not need to get approval as a stand alone device they only are going for approval as an adjunct to mammogram the only thing the FDA could say is: 1. change part of the study--unlikely as coii has been working with very qualified people on study design--and they will be talking with them starting months in advance of final submission--you can be sure they will be talking about all elements of the study design along with the individual modules. 2. the results are poor--unlikely as dave has said the results are better than they expected from samples taken i expect that there will be upward price movements as the word gets out that there is a new alternative to mammogram (even though it is not being billed as such). and, with no other competitor anywere in sight for the next year or so, we should command some public attention as dave and kathleen get the word out. therefore i assume we will rally and fall back to highers highs and lower lows as we approach the final decision. if FDA says no, the stock will tank, if FDA says yes, we will have had enough attention to this stock by next summer that a strong rally is highly possible by next summer/fall. curtis